Letter From The Editor

Just a little over 19 years ago, Steve Freed and I sent out our first Diabetes in Control newsletter. We had no journalism experience and we were definitely not webmasters, if the term even existed back then. We did have a great desire to share what we had learned about …

For the past couple of weeks Onyi Ibeji, our 4th Year Doctor of Pharmacy Candidate from LECOM College of Pharmacy, has been looking at the use of CGM in both adults and children. Like most younger medical professionals, she was not familiar with the challenges of technology and the reasons …

There have been many new drugs for diabetes in the last 10-12 years. It seems like we get one drug in a class, and then we suddenly have 3 or 4 and the class grows by leaps and bounds; just look at the GLP-1 Analogs as an example. I often …

Marian Ayad, our current PharmD candidate from University of Colorado, was questioning whether waiting till a patient was in their 30’s or 40’s was the best for performing gastric bypass. When she did her research she found out that the sooner the bypass is done, the better the outcomes, especially …

There are a lot of direct to consumer ads on TV these days. There is a lot of cultural diversity in the patients portrayed, and that lends itself to the assumption that these medications have the same effects across all racial segments. When you look deeper into the studies you …

Have you ever heard the old saying; “if it looks like a duck and quacks like a duck, then it must be a duck”? Well, this week Kassey James, our Pharm.D. Candidate from LECOM School of Pharmacy, brings us an article that proves that this is not always true. She …

I recently gave up my cable TV and DVR, and in order to get network channels I put a paper-thin HD antenna on my window to get them for free. The downside is that I sometimes have to watch commercials. I know that January is when all the fitness experts …

Thirty years ago most patients with type 2 diabetes did not develop the disease until they were in their late 60’s. They often did not develop the cardiovascular or kidney problems that we are so worried about today. This was likely due to their advanced age at diagnosis and a …

Last week our intern Marian Ayad, BSPharm, PharmD candidate, University of Colorado, was talking to me about the problems that occur when there is a lower age limit on the use of a medication. She had been reviewing PI’s on various diabetes medications and constantly found that most of them …

This is the last week that Emma Kammerer, L|E|C|O|M Bradenton School of Pharmacy, PharmD Candidate will be with us on her rotation. One of the topics we discussed was how to preserve beta cell function by starting aggressive management from day one. Like many pharmacists she was somewhat surprised by …